Optimal Combined Radio- and Anti-Angiogenic Cancer Therapy

被引:16
|
作者
Ledzewicz, Urszula [1 ,2 ]
Maurer, Helmut [3 ]
Schattler, Heinz [4 ]
机构
[1] Southern Illinois Univ, Edwardsville, IL 62026 USA
[2] Lodz Univ Technol, PL-90924 Lodz, Poland
[3] Westfal Wilhelms Univ Munster, D-48149 Munster, Germany
[4] Washington Univ, St Louis, MO 63130 USA
关键词
Optimal control; Combination therapy; Anti-angiogenic treatments; Radiotherapy; Numerical methods; Arc parameterization; 49K15; 92C50; TUMOR; RADIOTHERAPY; COMBINATION; EXTREMALS;
D O I
10.1007/s10957-018-1426-y
中图分类号
C93 [管理学]; O22 [运筹学];
学科分类号
070105 ; 12 ; 1201 ; 1202 ; 120202 ;
摘要
A mathematical model for combination of radio- and anti-angiogenic therapy is considered as optimal control problem with the objective of minimizing the tumor volume subject to isoperimetric constraints that limit the total radiation dose and the overall amount of anti-angiogenic agents to be given. The dynamics combines a model for tumor development under angiogenic inhibitors with the linear-quadratic model for the damage done by radiation ionization. The system has been investigated analytically as an optimal control problem and explicit expressions for possible singular controls were derived before. In this paper, for varying total radiation doses, examples of numerically computed optimal controls are given that verify and confirm these analytical structures: optimal schedules for the anti-angiogenic agents typically start with a brief full-dose segment, and then use up all inhibitors along a time-varying singular control while optimal radiotherapy schedules intensify the dosing and, after a brief period when the control is singular, end with a maximum dose segment. Singular controls occur for both the anti-angiogenic and radiotherapy dose rates. A discussion of the difficulties in proving the strong local optimality of corresponding trajectories is included.
引用
收藏
页码:321 / 340
页数:20
相关论文
共 50 条
  • [1] Optimal Combined Radio- and Anti-Angiogenic Cancer Therapy
    Urszula Ledzewicz
    Helmut Maurer
    Heinz Schättler
    Journal of Optimization Theory and Applications, 2019, 180 : 321 - 340
  • [2] Numerical Solution of an Optimal Control Problem in Cancer Treatment: Combined Radio and Anti-Angiogenic Therapy
    Chudej, Kurt
    Wagner, Lisa
    Pesch, Hans Josef
    IFAC PAPERSONLINE, 2015, 48 (01): : 665 - +
  • [3] Cancer anti-angiogenic therapy
    Shimizu, K
    Oku, N
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (05) : 599 - 605
  • [4] Biomarkers for Anti-Angiogenic Therapy in Cancer
    Wehland, Markus
    Bauer, Johann
    Magnusson, Nils E.
    Infanger, Manfred
    Grimm, Daniela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (05) : 9338 - 9364
  • [5] Anti-Angiogenic Cancer Therapy Updates
    Ali, A. M.
    Toi, M.
    Ueno, T.
    CURRENT MOLECULAR MEDICINE, 2009, 9 (08) : 954 - 966
  • [6] The promise of anti-angiogenic cancer therapy
    Oehler, MK
    Bicknell, R
    BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 749 - 752
  • [7] The promise of anti-angiogenic cancer therapy
    M K Oehler
    R Bicknell
    British Journal of Cancer, 2000, 82 : 749 - 752
  • [8] Anti-angiogenic therapy in breast cancer
    Rahman, MA
    Toi, M
    BIOMEDICINE & PHARMACOTHERAPY, 2003, 57 (10) : 463 - 470
  • [9] Optimal Controlled Trajectories for a Mathematical Model of Anti-Angiogenic Therapy in Cancer
    Ledzewicz, Urszula
    Schaettler, Heinz
    PROCEEDINGS OF THE 48TH IEEE CONFERENCE ON DECISION AND CONTROL, 2009 HELD JOINTLY WITH THE 2009 28TH CHINESE CONTROL CONFERENCE (CDC/CCC 2009), 2009, : 1201 - 1206
  • [10] Angiogenic signaling pathways and anti-angiogenic therapy for cancer
    Zhen-Ling Liu
    Huan-Huan Chen
    Li-Li Zheng
    Li-Ping Sun
    Lei Shi
    Signal Transduction and Targeted Therapy, 8